The present invention relates to a tosylate salt of Compound 1 and polymorphs thereof, in particular crystalline and amorphous forms of Compound 1 tosylate salt, and methods of preparation thereof. Pharmaceutical compositions containing these salts as active ingredient, their use in the manufacture of medicaments for use in the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body, and their use in methods for the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body are also described.
本发明涉及化合物1的对
磺酸盐及其多晶形式和非晶形式,特别是化合物1对
磺酸盐的晶体和非晶体形式,以及其制备方法。还描述了含有这些盐作为活性成分的药物组合物,它们用于制造用于治疗和/或预防人体或动物体内增生性疾病状态,如癌症的药物,并用于治疗和/或预防人体或动物体内增生性疾病状态,如癌症的方法。